Navigate the Future of Healthcare with Comprehensive Insights on the Expanding Implantable Infusion Pumps Market

DUBLIN, Sept. 29, 2023 /PRNewswire/ — The “Implantable Infusion Pumps Global Market Report 2023” has been added to’s offering.

The report provides an in-depth analysis of the global implantable infusion pumps market, a pivotal sector in contemporary healthcare. With chronic illnesses like diabetes, cancer, and pain disorders becoming alarmingly prevalent worldwide, implantable infusion pumps – including insulin pumps, PCA pumps, syringe pumps, and more –  are becoming indispensable.

These advanced devices, strategically placed within patients, hold the promise of precision in drug delivery, particularly critical in chronic pain, diabetes, and cancer treatments. The growing integration of wireless technologies is adding another layer of sophistication, enabling enhanced health monitoring and data connectivity.

Market Dynamics at a Glance:

  • Growth from $17.42 billion (2021) to $18.26 billion in 2022, marking a CAGR of 4.8%.
  • By 2026, market projections escalate to $21.79 billion with a CAGR of 4.5%.

The surge in chronic diseases, along with the increasing elderly population and evolving societal behaviors, have underscored the demand for implantable infusion pumps. Their precise drug delivery mechanisms offer efficient relief, especially in conditions such as chronic arachnoiditis.

However, the road isn’t without bumps. Concerns about the safety of these pumps, particularly during MRI examinations, have posed challenges. Despite adhering to specifications, MRI can alter the pump’s functionality, leading to adverse outcomes, as noted by the US Food and Drug Administration.

Yet, the market is responding proactively. Companies are pushing boundaries, aiming at developing ‘smart’ infusion pumps. The burgeoning use of wireless technology promises seamless data transfer to smart devices, reducing human errors, and elevating patient monitoring.

Geographical Highlights:

  • North America lead the pack in 2022.
  • Asia-Pacific followed closely, signifying growing market potential.

Market Segmentation Insights:

  • By Type: PCA Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, and more.
  • By Applications: Oncology, Pediatrics/Neonatology, Hematology, Diabetes, and beyond.
  • By End Users: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.

Global Coverage: Covering powerhouse countries from Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa, this report is exhaustive, encompassing market characteristics, growth patterns, segmentation, and the competitive landscape.

A glimpse into the companies sculpting this market: 

  • Medtronic
  • Boston Scientific Corporation
  • Nevro Corporation
  • Cyberonics
  • Baxter
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical
  • Terumo Corporation
  • Neuropace
  • Johnson & Johnson
  • Greatbatch Medical
  • St. Jude Medical
  • Neuropace
  • CareFusion Corporation
  • Primetech Corporation
  • Flowonix Medical Inc.
  • F. Hoffmann-La Roche Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Micrel Medical
  • Insulet Corporation
  • ICU Medical Inc.
  • Becton Dickinson (BD)

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


SOURCE Research and Markets

Originally published at

Part of VUGA

Part of VUGA

best company for press release distribution